IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort

E. Fontas , I. Kousignian (1) , C. Pradier , I. Poizot-Martin , C. Durier , L. Weiss , Y. Levy , D. Costagliola

1 UFR Pharmacie UPCité - UFR Pharmacie [Santé] - Université Paris Cité

Domaines: Santé publique et épidémiologie

E. Fontas, I. Kousignian, C. Pradier, I. Poizot-Martin, C. Durier, et al.. IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort. Journal of Antimicrobial Chemotherapy, 2010, 65 (10), pp.2215-2223. ⟨10.1093/jac/dkq296⟩. ⟨hal-03840551⟩